Publications by authors named "A Fatemi"

Background And Aim: Breast cancer and normal breast tissue exhibit different degrees of stiffness, indicating distinct biomechanical properties. Study results reveal that breast cancer tissue is several times stiffer than normal breast tissue. These variations can serve as indicative factors for imaging purposes.

View Article and Find Full Text PDF

Background And Aim: Multiparametric magnetic resonance imaging (mpMRI) is recognized as the most indicative method for diagnosing prostate cancer. The purpose of this narrative review is to provide a comprehensive evaluation aligned with the Prostate Imaging and Reporting Data System (PI-RADS) guidelines, offering an in-depth insight into the various MRI sequences used in a standard mpMRI protocol. Additionally, it outlines the critical technical requirements necessary to perform a standard mpMRI examination of the prostate, as defined by the PI-RADS specifications.

View Article and Find Full Text PDF

Background: Chronic Myeloid Leukemia (CML), accounting for 15-20% of adult leukemia cases, is marked by the Philadelphia chromosome, resulting from the t(9;22)(q34;q11) translocation. This leads to uncontrolled cell proliferation and survival. Imatinib therapy lowers BCR-ABL levels, influencing telomere-associated proteins and increasing telomerase accessibility, indirectly boosting its activity.

View Article and Find Full Text PDF

Although X-linked adrenoleukodystrophy (ALD) has historically been considered a childhood disease managed by pediatric neurologists, it is one of the most common leukodystrophies diagnosed in adulthood. An increase in both male and female adults reaching diagnosis due to familial cases identified by state newborn screening panels and more widespread use of genetic testing results in a large cohort of presymptomatic or early symptomatic adults. This population is in urgent need of standardized assessments and follow-up care.

View Article and Find Full Text PDF
Article Synopsis
  • The study introduces a practical method for creating Zinc Oxide nanoparticles (ZnO NPs) that can potentially combat leukemia by inducing ferroptosis, a form of programmed cell death.
  • Using a natural extract, the researchers synthesized and characterized ZnO NPs, and tested their effects on leukemic and normal cells at various concentrations over 24 and 48 hours.
  • Results showed that ZnO NPs successfully reduced leukemic cell survival without harming normal cells, indicating their potential as a complementary treatment in leukemia therapies by altering iron levels and increasing oxidative stress in cancer cells.
View Article and Find Full Text PDF